A cost-effectiveness analysis of pharmacotherapy versus prostatic urethral lift as initial therapy for patients with moderate benign prostatic hyperplasia
10.1080/14737167.2023.2144237
Saved in:
Main Authors: | Joshua Tung, Edwin Aslim, Henry Ho, Cynthia Chen |
---|---|
Other Authors: | SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH |
Format: | Article |
Published: |
Taylor & Francis
2023
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/237200 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Cost-effectiveness of alternative first- and second-line treatments for benign prostatic hyperplasia in Singapore
by: Junxing Chay, et al.
Published: (2024) -
Development of robotic interstitial laser therapy for benign prostatic hyperplasia
by: Shee, Cheng Yap.
Published: (2008) -
Understanding the role of estrogen in the development of benign prostatic hyperplasia
by: A. Ajayi, et al.
Published: (2019) -
Lack of association of VDR polymorphisms with thai prostate cancer as compared with benign prostate hyperplasia and controls
by: Suchart Chaimuangraj, et al.
Published: (2018) -
Minimally invasive surgery for benign prostatic hyperplasia--a review.
by: Kour, N.W.
Published: (2011)